SCHEMBL23053161

SCHEMBL23053161

CCOC(=O)COc1c2c(c(-c3ccc4c(c3)OCO4)c3cc(OC)c(OC)cc13)C(=O)OC2

nearest known ligand 0.81

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.72
KDM4E B2RXH2 4/20 0.72
MAPT P10636 3/20 0.72
NPSR1 Q6W5P4 2/20 0.72
HPGD P15428 3/20 0.66
LMNA P02545 2/20 0.66
MEN1 O00255 1/20 0.66
HTT P42858 1/20 0.66
KMT2A Q03164 1/20 0.66
ALOX5 P09917 4/20 0.53
TOP2A P11388 1/20 0.45
TP53 P04637 1/20 0.44
EDNRB P24530 7/20 0.43
EDNRA P25101 4/20 0.43
GAA P10253 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25943638 0.90 KDM4E (0.58) ALDH1A1KDM4EMAPTNPSR1HPGD
SCHEMBL23053117 0.90 KDM4E (0.76) ALDH1A1KDM4EMAPTNPSR1HPGD
SCHEMBL11954030 0.90 ALDH1A1 (0.75) ALDH1A1KDM4EMAPTNPSR1HPGD
SCHEMBL25944371 0.90 ALDH1A1 (0.70) ALDH1A1KDM4EMAPTNPSR1HPGD
SCHEMBL23053119 0.89 ALDH1A1 (0.75) ALDH1A1KDM4EMAPTNPSR1HPGD
SCHEMBL23053193 0.88 ALDH1A1 (0.72) ALDH1A1KDM4EMAPTNPSR1HPGD
SCHEMBL23053107 0.86 ALDH1A1 (0.75) ALDH1A1KDM4EMAPTNPSR1HPGD
SCHEMBL21383473 0.85 KDM4E (0.61) ALDH1A1KDM4EMAPTNPSR1HPGD
Justicidin A SCHEMBL168356 0.85 ALDH1A1 (0.82) ALDH1A1KDM4EMAPTNPSR1HPGD
Justicidin A SCHEMBL29731045 0.85 ALDH1A1 (0.82) ALDH1A1KDM4EMAPTNPSR1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230248754-A1 Patentiflorin A Analogs as Antiviral Agents HONG KONG BAPTIST UNIVERSITY (CN) 2023-08-10 US disclosed
US-11638713-B2 Patentiflorin A analogs as antiviral agents HONG KONG BAPTIST UNIVERSITY (CN) 2023-05-02 US disclosed
US-20210060042-A1 Patentiflorin A Analogs as Antiviral Agents HONG KONG BAPTIST UNIVERSITY (HK) 2021-03-04 US disclosed
WO-2021037077-A1 PATENTIFLORIN A ANALOGS AS ANTIVIRAL AGENTS HONG KONG BAPTIST UNIVERSITY (CN) 2021-03-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230248754-A1 Patentiflorin A Analogs as Antiviral Agents MAVS, MIF, SARS1 ALDH1A1 2987/4885KDM4E 4386/4885MAPT 2419/4885
US-11638713-B2 Patentiflorin A analogs as antiviral agents MAVS, MIF, SARS1 ALDH1A1 2987/4885KDM4E 4386/4885MAPT 2419/4885
US-20210060042-A1 Patentiflorin A Analogs as Antiviral Agents MAVS, MIF, SARS1 ALDH1A1 2987/4885KDM4E 4386/4885MAPT 2419/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.